Recently, Udea and colleagues described the generation of a novel anti-human LAT1 monoclonal antibody based on the rat Ig2a heavy chain which when bound to human LAT1 blocked the uptake of BCAAs and blunted tumor growth (43). The gene discussed is SLC7A5; the disease is neoplasm.